{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T14:16:25Z","timestamp":1776867385350,"version":"3.51.2"},"reference-count":76,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.ad.2012.12.019","type":"journal-article","created":{"date-parts":[[2013,5,7]],"date-time":"2013-05-07T23:57:47Z","timestamp":1367971067000},"page":"469-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Actualizaci\u00f3n en el tratamiento de la urticaria cr\u00f3nica"],"prefix":"10.1016","volume":"105","author":[{"given":"L.","family":"Curto-Barredo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.F.","family":"Silvestre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Gim\u00e9nez-Arnau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2012.12.019_bib0005","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1398-9995.2009.02179.x","article-title":"EAACI\/GA2LEN\/EDF guideline: definition, classification and diagnosis of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"BSACI guidelines for the management of chronic urticaria and angio-oedema","volume":"37","author":"Powel","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/0128071-200910010-00002","article-title":"Urticaria. A review","volume":"10","author":"Poonawalla","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0020","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaci.2004.02.049","article-title":"Chronic urticaria: pathogenesis and treatment","volume":"114","author":"Kaplan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0025","first-page":"114","article-title":"Unmet clinical needs in chronic urticaria","volume":"109","author":"Maurer","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mai.2002.120954","article-title":"A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria","volume":"109","author":"Kikuchi","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0035","first-page":"214","article-title":"Epidemiology of urticaria in Spain","volume":"14","author":"Gaig","year":"2004","journal-title":"Investig Allergol Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2133.2005.06385.x","article-title":"Comparative study of the impact of chronic urticaria, psoriasis and atopic dermatitis on the quality of life","volume":"152","author":"Grob","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0050","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA2LEN\/EDF guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0055","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1365-2133.2001.04175.x","article-title":"Management and diagnostic guidelines for urticaria and angio-oedema","volume":"144","author":"Grattan","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0060","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0091-6749(80)90215-8","article-title":"Skin histamine in chronic urticaria","volume":"65","author":"Phanuphak","year":"1980","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0065","first-page":"41","article-title":"Antihistamines in the treatment of chronic urticaria","volume":"17","author":"J\u00e1uregui","year":"2007","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1398-9995.2008.01640.x","article-title":"Rupatadine in allergic rhinitis and chronic urticaria","volume":"63","author":"Mullol","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0075","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1111\/j.1468-3083.2009.03289.x","article-title":"The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo controlled treatment with rupatadine 10 and 20mg","volume":"23","author":"Gimenez-Arnau","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ad.2012.12.019_bib0080","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaci.2010.01.056","article-title":"Activation of human mast cells through the platelet-activating factor receptor","volume":"125","author":"Kajiwara","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"suppl 2","key":"10.1016\/j.ad.2012.12.019_bib0085","first-page":"S14","article-title":"Intradermal injections of platelet-activating factor (PAF) result in wheal-and-flare type skin reactions but do not induce mast cell degranulation","volume":"131","author":"Krause","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2165\/00128071-200102010-00005","article-title":"Treatment of urticaria. An evidence-based evaluation of antihistamines","volume":"2","author":"Lee","year":"2001","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0095","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1177\/106002809603001001","article-title":"Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria","volume":"30","author":"Breneman","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ad.2012.12.019_bib0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2009.11.047","article-title":"The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria","volume":"125","author":"Staevska","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0105","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1398-9995.2008.01893.x","article-title":"Comparison of the efficacy of levocetirizine 5mg and desloratadine 5mg in chronic idiopathic urticaria patients","volume":"64","author":"Potter","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0110","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2500\/aap.2009.30.3226","article-title":"The concept of receptor occupancy to predict clinical efficacy: a comparison of second generation H1 antihistamines","volume":"30","author":"Gillman","year":"2009","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.ad.2012.12.019_bib0115","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2133.2007.08283.x","article-title":"Guidelines for evaluation and management of urticaria in adults and children","volume":"157","author":"Grattan","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0120","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2165\/00003495-199346060-00008","article-title":"Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders","volume":"46","author":"Spencer","year":"1993","journal-title":"Drug"},{"key":"10.1016\/j.ad.2012.12.019_bib0125","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)61995-3","article-title":"A double-blind, randomized, single dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine and placebo: suppression of histamine-induced wheal-and-flare response during 24hours in healthy male subjects","volume":"88","author":"Grant","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0130","first-page":"283","article-title":"Antiallergic properties of loratadine: a review","volume":"12","author":"Bousquet","year":"1995","journal-title":"Adv Ther"},{"issue":"Suppl. 65","key":"10.1016\/j.ad.2012.12.019_bib0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1398-9995.2001.00101.x","article-title":"The pharmacologic profile of desloratadine: a review","volume":"56","author":"Henz","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1398-9995.2001.00104.x","article-title":"Desloratadine in the treatment of chronic idiopathic urticaria","volume":"56","author":"Ring","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1398-9995.2008.01897.x","article-title":"Ebastine in allergic rhinitis and chronic idiopathic urticaria","volume":"63","author":"Sastre","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1398-9995.2007.01330.x","article-title":"Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study","volume":"62","author":"Gimenez-Arnau","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1586\/eci.10.85","article-title":"Rupatadine for the treatment of allergic rhinitis and urticaria","volume":"7","author":"Metz","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000321896","article-title":"Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials","volume":"156","author":"Compalati","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0165","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/ACI.0b013e32833bfa20","article-title":"Recent advances in antileukotriene therapy","volume":"10","author":"Scadding","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/09546630802607495","article-title":"Efficacy of leukotriene receptor antagonist with an anti-H1 receptor antagonist for treatment of chronic idiopathic urticaria","volume":"20","author":"Kong-Sang","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.ad.2012.12.019_bib0175","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.4049\/jimmunol.151.10.5563","article-title":"In vivo characterization of the anti-inflammatory effect of cyclosporine A on human basophils","volume":"151","author":"Casolmo","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0180","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1523-1747.ep12499960","article-title":"Anti-inflammatory effect of cyclosporin A on human skin mast cells","volume":"98","author":"Stellato","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0185","first-page":"285","article-title":"Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation","volume":"24","author":"Di Gioacchino","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.ad.2012.12.019_bib0190","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.2000.03664.x","article-title":"Randomized double-blind study of cyclosporin in chronic \u00abidiopathic\u00bb urticaria","volume":"143","author":"Grattan","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0195","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1385\/CRIAI:23:2:233","article-title":"Treatment of patients with chronic idiopathic urticaria","volume":"23","author":"Stanaland","year":"2002","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0200","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-4632.2006.02655.x","article-title":"Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and\/or corticosteroids","volume":"45","author":"Shahar","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2011.06.004","article-title":"The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patients","volume":"66","author":"Zimmerman","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1081-1206(10)61941-2","article-title":"Successful treatment of autoimmune chronic idiopathic urticaria with intravenous cyclophosphamide","volume":"89","author":"Bernstein","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2009.09538.x","article-title":"Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria","volume":"162","author":"Perez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0220","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jaci.2006.12.658","article-title":"Successful treatment of delayed pressure urticaria with anti-TNF-alfa","volume":"119","author":"Magerl","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2340\/0001555565449450","article-title":"Ultraviolet light therapy in chronic urticaria","volume":"65","author":"Hannuksela","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2012.12.019_bib0230","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2340\/00015555-0434","article-title":"Treatment of chronic urticaria with narrowband ultraviolet B phototherapy: a randomized controlled trial","volume":"88","author":"Engin","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2012.12.019_bib0235","first-page":"32","article-title":"Inmunoglobulina endovenosa en enfermedades neuromusculares. Gu\u00edas para su utilizaci\u00f3n","volume":"31","author":"Figueredo","year":"2006","journal-title":"Rev Neurol Arg"},{"key":"10.1016\/j.ad.2012.12.019_bib0240","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","article-title":"Intravenous immunoglobulin in autoimmune chronic urticaria","volume":"138","author":"O\u2019Donnell","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0245","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jaad.2010.05.040","article-title":"Solar urticaria treated with intravenous immunoglobulins","volume":"65","author":"Adamski","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0250","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0140-6736(92)90666-Q","article-title":"Plasmapheresis for severe, unremitting, chronic urticaria","volume":"339","author":"Grattan","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2012.12.019_bib0255","first-page":"133","article-title":"Anti-IgE (omalizumab) in the treatment of allergic rhinitis","volume":"19","author":"F\u00e9lix Toledo","year":"2004","journal-title":"Alergol inmunol Clin"},{"key":"10.1016\/j.ad.2012.12.019_bib0260","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0265","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2222.1991.tb03198.x","article-title":"Detection of circulating histamine releasing autoantibodies with functional properties of anti-IgE in chronic urticaria","volume":"21","author":"Grattan","year":"1991","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0270","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1016\/j.jaci.2007.12.1121","article-title":"Effect of Anti-IgE (omalizumab) in chronic idiopathic urticaria (CIU) patients","volume":"121","author":"Gober","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0275","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2010.05.047","article-title":"Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab","volume":"126","author":"Magerl","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60644-8","article-title":"Effect of omalizumab on patients with chronic urticaria","volume":"99","author":"Spector","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0285","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0295","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1398-9995.2008.01879.x","article-title":"Successful treatment of solar urticaria with anti-immunoglobulin E therapy","volume":"63","author":"G\u00fczelbey","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0300","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.jaci.2009.11.007","article-title":"Partial improvement of solar urticaria after omalizumab","volume":"125","author":"Waibel","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0305","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1398-9995.2009.02268.x","article-title":"Effective treatment of refractory severe heat urticaria with omalizumab","volume":"65","author":"Bullerkotte","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0310","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1398-9995.2009.02188.x","article-title":"Efficacy of omalizumab in delayed pressure urticaria: a case report","volume":"65","author":"Bindslev-Jensen","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2230.2009.03748.x","article-title":"Failure of omalizumab in cholinergic urticaria","volume":"35","author":"Sabroe","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jaci.2011.06.010","article-title":"A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine refractory chronic idiopathic urticaria","volume":"128","author":"Saini","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0325","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0091-6749(89)90011-0","article-title":"Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial","volume":"83","author":"Bressler","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0330","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jaci.2005.12.1343","article-title":"Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum","volume":"117","author":"Asero","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0335","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaci.2006.08.043","article-title":"Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria","volume":"119","author":"Asero","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1398-9995.2007.01514.x","article-title":"Severe chronic urticaria is associated with elevated plasma levels of D-dimer","volume":"63","author":"Asero","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0345","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1398-9995.2009.02222.x","article-title":"Coagulation\/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria","volume":"65","author":"Takahagi","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0350","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000292947","article-title":"Heparin and tranexamic acid therapy may be effective in treatment-resistant chronic urticaria with elevated D-Dimer: a pilot study","volume":"152","author":"Asero","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0355","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1034\/j.1398-9995.1999.00187.x","article-title":"Urticaria treated with dapsone","volume":"54","author":"Boehm","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.ad.2012.12.019_bib0360","first-page":"2429","article-title":"Colchicine for prophylaxis of acute flares when initiating allopurinol for chronic gouty arthritis","volume":"31","author":"Borstad","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0365","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0190-9622(98)70275-0","article-title":"Colchicine in dermatology","volume":"39","author":"Sullivan","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2012.12.019_bib0370","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.4049\/jimmunol.174.8.4584","article-title":"Microtubule disruption suppresses allergic response through the inhibition of calcium influx in the mast cell degranulation pathway","volume":"174","author":"Oka","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ad.2012.12.019_bib0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/000155501750208344","article-title":"Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria","volume":"81","author":"Hartmann k","year":"2000","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2012.12.019_bib0380","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/0091-6749(84)90518-9","article-title":"The hypocomplementemic urticarial-vasculitis syndrome: therapeutic response to hydroxychloroquine","volume":"73","author":"Lopez","year":"1984","journal-title":"J Allergy Clin Immunol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731013001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:01:55Z","timestamp":1757552515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731013001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":76,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0001731013001099"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2012.12.019","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Actualizaci\u00f3n en el tratamiento de la urticaria cr\u00f3nica","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2012.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Espa\u00f1a, S.L. and AEDV. All rights reserved.","name":"copyright","label":"Copyright"}]}}